Current Controlled Trials (CCT), which aims ‘to increase the availability, and promote the exchange, of information
about ongoing randomised controlled trials worldwide,’ has appointed a new advisory board to help it in its work. Other than yours truly, the Board includes Ben Goldacre and Paul Wicks (PatientsLikeMe) among its members, and is drawing on international expertise as well.
This is a really impressive operation with real ambitions to innovate and improve the information on trials that is available to professionals and the public. So you might want to bookmark their blog or become a follower to stay up-to-date with new developments.
I feel rather honoured to have been asked to join and am very excited about getting down to work.